Correction to Lancet Oncol 2017; 18: 63-74

Published Erratum

. 2017 Jun;18(6):e301.

doi: 10.1016/S1470-2045(17)30368-6.

No authors listed

Published Erratum

No authors listed. Lancet Oncol. 2017 Jun.

. 2017 Jun;18(6):e301.

doi: 10.1016/S1470-2045(17)30368-6.

No abstract available

Erratum for

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.
Freyer DR, Chen L, Krailo MD, Knight K, Villaluna D, Bliss B, Pollock BH, Ramdas J, Lange B, Van Hoff D, VanSoelen ML, Wiernikowski J, Neuwelt EA, Sung L. Freyer DR, et al. Lancet Oncol. 2017 Jan;18(1):63-74. doi: 10.1016/S1470-2045(16)30625-8. Epub 2016 Dec 1. Lancet Oncol. 2017. PMID: 27914822 Free PMC article. Clinical Trial.

Correction to Lancet Oncol 2022; 23 (Abstracts from the The Lancet Summit: Cancer care in Asia and Latin America Special Issue): S11.
[No authors listed] [No authors listed] Lancet Oncol. 2022 Jul 20:S1470-2045(22)00485-5. doi: 10.1016/S1470-2045(22)00485-5. Online ahead of print. Lancet Oncol. 2022. PMID: 35870470 No abstract available.
Correction to Lancet Oncol 2017; 18: 812.
[No authors listed] [No authors listed] Lancet Oncol. 2017 Jun;18(6):e301. doi: 10.1016/S1470-2045(17)30371-6. Lancet Oncol. 2017. PMID: 28593858 No abstract available.
Correction to Lancet Oncol 2017; 18: e186.
[No authors listed] [No authors listed] Lancet Oncol. 2017 May;18(5):e245. doi: 10.1016/S1470-2045(17)30275-9. Lancet Oncol. 2017. PMID: 28495290 No abstract available.
Correction to Lancet Oncol 2016; 17: 234-42.
[No authors listed] [No authors listed] Lancet Oncol. 2017 Mar;18(3):e134. doi: 10.1016/S1470-2045(17)30077-3. Epub 2017 Mar 2. Lancet Oncol. 2017. PMID: 28271868 No abstract available.
Correction to Lancet Oncol 2016; 17: e506.
[No authors listed] [No authors listed] Lancet Oncol. 2017 Mar;18(3):e134. doi: 10.1016/S1470-2045(17)30094-3. Epub 2017 Mar 2. Lancet Oncol. 2017. PMID: 28271867 No abstract available.